» Articles » PMID: 33488878

Safety, Efficacy, Length of Stay and Patient Satisfaction with Outpatient Management of Low-risk Pulmonary Embolism Patients - a Meta-analysis

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2021 Jan 25
PMID 33488878
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Annual health expense of hospital admissions, due to venous thromboembolism including pulmonary embolism, exceeds 10 billion dollars in the United States. Most of these patients still get admitted to the hospital despite the advent of novel oral anticoagulants. Our aim is to show that low-risk pulmonary embolism patients can safely be discharged from the emergency department with similar patient satisfaction and lower length of stay.

Methods: A comprehensive search in Medline indexed and non-indexed, Embase, and Cochrane Central was performed to search for all the randomized controlled trials that compared inpatient treatment of low-risk pulmonary embolism to outpatient treatment.

Results: Of 68 potentially relevant studies, a total of 2 studies (453 participants) met our inclusion criteria and had data available on patient satisfaction, length of stay, efficacy, and patient safety. The pooled estimate of the included studies showed that at 3-month follow-up, there was no statistically significant difference between inpatient and outpatient treatment of these low-risk patients.

Conclusions: In conclusion, our meta-analysis of 2 randomized controlled trials shows that low-risk pulmonary embolism patients can safely be discharged from the emergency departments in the limited studies available. We need more randomized controlled trials to confirm these findings.

Citing Articles

A clinical decision framework to guide the outpatient treatment of emergency department patients diagnosed with acute pulmonary embolism or deep vein thrombosis: Results from a multidisciplinary consensus panel.

Kabrhel C, Vinson D, Mitchell A, Rosovsky R, Chang A, Hernandez-Nino J J Am Coll Emerg Physicians Open. 2021; 2(6):e12588.

PMID: 34950930 PMC: 8673564. DOI: 10.1002/emp2.12588.

References
1.
Dasta J, Pilon D, Mody S, Lopatto J, Laliberte F, Germain G . Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy. Thromb Res. 2015; 135(2):303-10. DOI: 10.1016/j.thromres.2014.11.024. View

2.
Kearon C, Akl E, Ornelas J, Blaivas A, Jimenez D, Bounameaux H . Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016; 149(2):315-352. DOI: 10.1016/j.chest.2015.11.026. View

3.
Otero R, Uresandi F, Jimenez D, Cabezudo M, Oribe M, Nauffal D . Home treatment in pulmonary embolism. Thromb Res. 2009; 126(1):e1-5. DOI: 10.1016/j.thromres.2009.09.026. View

4.
Agterof M, Schutgens R, Snijder R, Epping G, Peltenburg H, Posthuma E . Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost. 2010; 8(6):1235-41. DOI: 10.1111/j.1538-7836.2010.03831.x. View

5.
Bledsoe J, Woller S, Stevens S, Aston V, Patten R, Allen T . Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization: The Low-Risk Pulmonary Embolism Prospective Management Study. Chest. 2018; 154(2):249-256. DOI: 10.1016/j.chest.2018.01.035. View